by Mark Shelton, University of Massachusetts Medical School Graphical abstract. Credit: Cell Reports (2022). DOI: 10.1016/j.celrep.2022.110952 A new paper from the laboratory of Lawrence Stern, Ph.D., indicates that some of the antigens on the virus that causes COVID-19 are common across all the human coronaviruses, such as those that cause the common cold, and that one particular...
By Neha Mathur Jul 18 2022 Reviewed by Aimee Molineux In a recent study posted to the bioRxiv* pre-print server, researchers evaluated the activity of nitazoxanide against human coronaviruses (HCoVs). Study: Nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on viral spike glycoprotein. Image Credit: StudioMolekuul/Shutterstock. Background Identified first in the 1960s, HCoVs...
